 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 16 | 5 | 21 | | 1997 | 25 | 2 | 27 | | 1998 | 13 | 2 | 15 | | 1999 | 12 | 2 | 14 | | 2000 | 16 | 1 | 17 | | 2001 | 14 | 7 | 21 | | 2002 | 38 | 8 | 46 | | 2003 | 22 | 3 | 25 | | 2004 | 33 | 5 | 38 | | 2005 | 37 | 3 | 40 | | 2006 | 36 | 9 | 45 | | 2007 | 45 | 8 | 53 | | 2008 | 39 | 7 | 46 | | 2009 | 40 | 4 | 44 | | 2010 | 55 | 4 | 59 | | 2011 | 39 | 4 | 43 | | 2012 | 60 | 5 | 65 | | 2013 | 69 | 12 | 81 | | 2014 | 74 | 8 | 82 | | 2015 | 67 | 9 | 76 | | 2016 | 82 | 8 | 90 | | 2017 | 81 | 9 | 90 | | 2018 | 91 | 10 | 101 | | 2019 | 85 | 4 | 89 | | 2020 | 85 | 6 | 91 | | 2021 | 87 | 2 | 89 | | 2022 | 93 | 1 | 94 | | 2023 | 91 | 2 | 93 | | 2024 | 58 | 5 | 63 | | 2025 | 65 | 3 | 68 | | 2026 | 44 | 3 | 47 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Horiike A, Wakui H, Sugawara S, Minegishi Y, Tasaka S, Kusumoto S, Sakatani T, Suzuki H, Hosomi Y, Tambo Y, Shimokawa T, Ishida H, Miyauchi E, Naoki K, Fukuhara T, Mura E, Tsurui T, Suzuki R, Iriguchi N, Ishiguro T, Hirasawa Y, Manabe R, Shimokawa M, Ohkuma R, Ariizumi H, Kubota Y, Hamada K, Takenoshita S, Ryu K, Sambe T, Inoue E, Wada S, Yoshimura K, Sagara H, Kobayashi S, Tsunoda T. Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non-Small Cell Lung Cancer with =50% PD-L1 Expression: A Nonrandomized Phase II Trial. Clin Cancer Res. 2026 Oct 15; 32(20):4571-4579.
-
Florez N, Patel SP, Salgia R, Sands J, Schenk EL, Shum E, Aldea M, Bestvina CM, Donington J, Garcia CA, Nieva J, Gandara DR, Halmos B, Hirsch FR, Le X, Lee P, Malhotra J, Patil T, Peters S, Riess JW, Rotow J, Rous FA, Sabari J, Sen T, Singhi EK, Velázquez AI, Wakelee HA, Kim ES. Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025. Cancer. 2026 Oct 01; 132(19):e70633.
-
Sharma JR, Singh V, Kandhari K, Agraval H. From smoke to stemness: Mechanisms of cancer stem cell induction by cigarette smoke. Biochim Biophys Acta Rev Cancer. 2026 Oct; 1881(5):189700.
-
Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2026 Sep; 27(9):1094-1109.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI. Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer. 2026 Nov; 73(11):e70639.
-
Sullivan DC, McNitt-Gray M, Aberle DR, Avila RS, Armato SG, Bergstrom PM, Chong M, Cody DD, Coombs LP, Frank RA, Gillies RJ, Goldin JG, Kalpathy-Cramer J, Kinahan PE, Schabath MB, Smith RA, Yankelevitz DF, Kazerooni EA. The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum. Cancer. 2026 Aug 15; 132(16):e70516.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.
-
Contreras-Zárate MJ, Jaramillo-Gómez JA, Marquez-Ortiz RA, Pham TC, Koliavas SN, Ormond DR, Navarro AC, Nemenoff RA, Camidge DR, Cittelly DM. Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases. Cancer Res Commun. 2026 Aug 01; 6(8):1850-1861.
-
Phillips WJ, Leong R, Yeung B, Al Lawati A, Camidge DR, Lo B, Wheatley-Price P. The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC. Curr Oncol. 2026 Jul 23; 33(8).
-
Fox AH, Ward RC, Alexander M, Osarogiagbon RU, Smith RA, Studts JL, Silvestri GA. Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults. JAMA Oncol. 2026 Jul 01; 12(7):705-713.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|